Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
FEMALE
NCT06884852

Ultrasound-guided Multilevel Erectorspinae Plane Block Versus Thoracic Epidural Analgesia for Prevention of Post Mastectomy Pain Syndrome for Breast Cancer Patients

Led by National Cancer Institute, Egypt · Updated on 2025-05-21

44

Participants Needed

1

Research Sites

49 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aim of this study is to compare the analgesic efficacy of multilevel erector spinae plane block (ESPB) vs thoracic epidural in modified radical mastectomy (MRM) regarding duration of analgesia, postoperative opioid consumption, effect on intraoperative fentanyl consumption, postoperative numerical pain rating scale and quality of life for the next 6 months.

CONDITIONS

Official Title

Ultrasound-guided Multilevel Erectorspinae Plane Block Versus Thoracic Epidural Analgesia for Prevention of Post Mastectomy Pain Syndrome for Breast Cancer Patients

Who Can Participate

Age: 18Years - 65Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female patients age 64 18 years and 64 65 years
  • Scheduled for Modified Radical Mastectomy (MRM) surgery
  • Physical status ASA II or III
  • Body mass index (BMI) greater than 20 kg/m2 and less than 35 kg/m2
Not Eligible

You will not qualify if you...

  • Patient refusal to participate
  • Allergy or contraindication to drugs used in the study such as local anesthetics or opioids
  • History of psychological disorders
  • History of chronic pain
  • Contraindications to regional anesthesia such as sepsis, peripheral neuropathies, or coagulopathy
  • Advanced chronic kidney disease with a glomerular filtration rate less than 30 ml/min (stages 4 and 5)
  • Decompensated liver cirrhosis characterized by serious liver complications
  • Severe heart disease classified as NYHA class III or IV
  • Severe lung disease including low oxygen saturation (less than 92%), high respiratory rate (more than 20), or FEV1/FVC ratio less than 60%
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Cancer Institute

Cairo, Egypt, 11796

Actively Recruiting

Loading map...

Research Team

A

Ahmed El Abdelaal, Master

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here